LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 40.14 | 84.90 | 218 | 3682 | 0.0592 | 0.1893 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 40.14 | 84.90 | 3220 | 3682 | 0.8745 | 0.9513 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 40.14 | 84.90 | 150 | 3682 | 0.0407 | 0.1103 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 40.14 | 84.90 | 3525 | 3682 | 0.9573 | 0.9840 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 41.84 | 84.90 | 3664 | 4003 | 0.9153 | 0.9684 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 41.84 | 84.90 | 3689 | 4003 | 0.9215 | 0.9708 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 41.84 | 84.90 | 3968 | 4003 | 0.9912 | 0.9968 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 41.84 | 84.90 | 4010 | 4003 | 1.0017 | 1.0006 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 41.84 | 84.90 | 257 | 4003 | 0.0642 | 0.2205 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 41.84 | 84.90 | 3533 | 4003 | 0.8826 | 0.9556 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 41.84 | 84.90 | 123 | 4003 | 0.0307 | 0.0690 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 41.84 | 84.90 | 3773 | 4003 | 0.9425 | 0.9788 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 43.55 | 84.90 | 3856 | 4287 | 0.8993 | 0.9628 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 43.55 | 84.90 | 3882 | 4287 | 0.9053 | 0.9652 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 43.55 | 84.90 | 4215 | 4287 | 0.9830 | 0.9940 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 43.55 | 84.90 | 4263 | 4287 | 0.9942 | 0.9979 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 43.55 | 84.90 | 306 | 4287 | 0.0714 | 0.2543 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 43.55 | 84.90 | 3769 | 4287 | 0.8790 | 0.9549 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 43.55 | 84.90 | 163 | 4287 | 0.0380 | 0.1222 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 43.55 | 84.90 | 4059 | 4287 | 0.9466 | 0.9807 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 45.25 | 84.90 | 4107 | 4539 | 0.9047 | 0.9654 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 45.25 | 84.90 | 4133 | 4539 | 0.9104 | 0.9676 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 45.25 | 84.90 | 4549 | 4539 | 1.0020 | 1.0007 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 45.25 | 84.90 | 4623 | 4539 | 1.0183 | 1.0063 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 45.25 | 84.90 | 343 | 4539 | 0.0756 | 0.2754 | MN20160318_Q02 | G14 |